Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer
Bulkiness of primary prostate tumor was associated with worse outcomes in patients with mHSPC. Men with cT4 will require multimodal and intensive therapeutic strategies irrespective of tumor volume.
Authors
- Tomohisa Matsunaga (ORCID: https://orcid.org/0000-0001-5238-2598)
- Takuya Tsujino (ORCID: https://orcid.org/0000-0003-1559-1889)
- Shinichi Sakamoto (ORCID: https://orcid.org/0000-0002-7508-7521)
- Tomokazu Sazuka (ORCID: https://orcid.org/0000-0002-8902-7853)
- Ryoichi Maenosono (ORCID: https://orcid.org/0000-0002-9045-5484)
- Yuki Yoshikawa (ORCID: https://orcid.org/0000-0001-8834-5051)
- Haruhito Azuma (ORCID: https://orcid.org/0000-0001-5497-1679)
- Atsushi Komaru (ORCID: https://orcid.org/0000-0002-6350-3436)
- Manato Kanesaka
- Kazuki Nishimura (ORCID: https://orcid.org/0000-0002-2878-7664)
- Satoshi Fukasawa (ORCID: https://orcid.org/0000-0002-4759-4999)
- Ko Nakamura (ORCID: https://orcid.org/0000-0002-8734-2147)
- Hiroomi Nakatsu
- Yusuke Imamura (ORCID: https://orcid.org/0009-0006-7207-1520)
- Yukio Naya (ORCID: https://orcid.org/0000-0002-2008-6951)
- Kazumasa Komura (ORCID: https://orcid.org/0000-0003-4157-1929)
- Yasutaka Yamada (ORCID: https://orcid.org/0000-0002-0070-1590)
- Takayuki Arai (ORCID: https://orcid.org/0000-0002-3888-9576)
- Kodai Sato (ORCID: https://orcid.org/0000-0001-6914-4991)
- Maki Nagata
- Kazuyoshi Nakamura (ORCID: https://orcid.org/0000-0003-0516-8913)
- Kazuto Chiba
- Tatsuo Fukushima (ORCID: https://orcid.org/0009-0002-2823-0628)
- Tomohiko Ichikawa
- Sanae Saito
- Kazuo Mikami
Institutions
- Chiba University (JP)
- Chibaken Saiseikai Narashino Hospital (JP)
- Kin-ikyo Chuo Hospital (JP)
- Chiba Cancer Center (JP)
- Teikyo University Chiba Medical Center (JP)
- Yokohama Rosai Hospital (JP)
- Funabashi Municipal Medical Center (JP)
- Asahi General Hospital (JP)
- Saitama Red Cross Hospital (JP)
- Osaka University of Pharmaceutical Sciences (JP)
Publication Details
- Journal
- Prostate International
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1016/j.prnil.2024.11.005
- Citations
- 5
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Uehara Memorial Foundation
- Nippon Shinyaku
- Astellas Pharma
- Astellas Foundation for Research on Metabolic Disorders
- Japanese Foundation for Prostate Research
- Japan Society for the Promotion of Science